Fidelity SPDR Advertisement
Home > Boards > Free Zone > User's Groups > S2 Option Trader

Dude, while you sometimes post a usefull, informative

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
robanson Member Profile
 
Followed By 0
Posts 104
Boards Moderated 0
Alias Born 07/03/06
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Whistleblowers Score a Big Payday -- Update
Mobile's Rise Poses a Riddle for Banks
AT&T Boosts Dividend
U.S. Hot Stocks: Hot Stocks to Watch
Brazilian Shares Rise, Led by Rossi Residencial; Real Weakens Slightly
Oracle Beats Street View for First Time in a Year
Alstom CEO Expects to Settle DOJ Bribery Allegations Very Soon
robanson   Saturday, 06/18/11 11:41:47 PM
Re: plashadpobedy post# 1280
Post # of 1298 
Dude, while you sometimes post a usefull, informative post your bashing of S2's recommendations (and S2 personally) are annoying. Anyone who has been a follower of S2 has learned way more about trading and the markets than on any other discussion board. Usually your posts are spitefull and pathetic...find some other board to bash or offer an insightfull, intelligent counterpoint to what S2 is trying to do here. Even if he only posts about once a month.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist